Tenascin is increased in cartilage and synovium from arthritic knees.

PubWeight™: 1.75‹?› | Rank: Top 3%

🔗 View Article (PMID 7690296)

Published in Br J Rheumatol on September 01, 1993

Authors

D M Salter1

Author Affiliations

1: Department of Pathology, University of Edinburgh Medical School.

Articles citing this

Tenascin-C is an endogenous activator of Toll-like receptor 4 that is essential for maintaining inflammation in arthritic joint disease. Nat Med (2009) 3.87

DAMPening inflammation by modulating TLR signalling. Mediators Inflamm (2010) 3.29

A type 2 (Th2-like) pattern of immune response predominates in the pulmonary interstitium of patients with cryptogenic fibrosing alveolitis (CFA). Clin Exp Immunol (1995) 1.50

The role of changes in extracellular matrix of cartilage in the presence of inflammation on the pathology of osteoarthritis. Biomed Res Int (2013) 1.18

Integrin-regulated secretion of interleukin 4: A novel pathway of mechanotransduction in human articular chondrocytes. J Cell Biol (1999) 1.07

Tenascin-C and human tendon degeneration. Am J Pathol (1996) 1.06

The fibrinogen globe of tenascin-C promotes basic fibroblast growth factor-induced endothelial cell elongation. Mol Biol Cell (1999) 0.93

Tenascin-C induces inflammatory mediators and matrix degradation in osteoarthritic cartilage. BMC Musculoskelet Disord (2011) 0.91

Tenascin and aggrecan expression by articular chondrocytes is influenced by interleukin 1beta: a possible explanation for the changes in matrix synthesis during osteoarthritis. Ann Rheum Dis (2004) 0.91

Expression of tenascin in joint-associated tissues during development and postnatal growth. J Anat (1996) 0.88

Problems and paradigms in joint pathology. J Anat (1994) 0.85

Identification of an immunodominant peptide from citrullinated tenascin-C as a major target for autoantibodies in rheumatoid arthritis. Ann Rheum Dis (2015) 0.85

Tenascin-C fragments are endogenous inducers of cartilage matrix degradation. Rheumatol Int (2011) 0.82

Raised circulating tenascin-C in rheumatoid arthritis. Arthritis Res Ther (2012) 0.80

Expression of tenascin-C in aseptic loosening of total hip replacement. Ann Rheum Dis (1998) 0.76

Tenascin and arthritis. Br J Rheumatol (1994) 0.75

Therapeutics for tendon regeneration: a multidisciplinary review of tendon research for improved healing. Ann N Y Acad Sci (2016) 0.75

Articles by these authors

Integrin expression by human articular chondrocytes. Br J Rheumatol (1992) 1.04